Adjuvant imatinib mesylate reduces risk of gastrointestinal stromal tumor recurrence

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2009年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：555 / 555
页数：1
相关论文
共 50 条
  • [21] Recurrence after imatinib treatment for patients with gastrointestinal stromal tumor
    Sawaki, Akira
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A499 - A499
  • [22] Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: a retrospective cohort study
    Wan, Qianyi
    Xu, Mei
    Zhao, Rui
    Wang, Yong
    Wu, Yutao
    Shen, Xiaoding
    Wu, Xiaoting
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (06) : 1493 - 1500
  • [23] Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate
    Ferraresi, Virginia
    Catricala, Caterina
    Ciccarese, Mariangela
    Ferrari, Angela
    Zeuli, Massimo
    Cognetti, Francesco
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4771 - 4774
  • [24] Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
    Bauer, S
    Corless, CL
    Heinrich, MC
    Dirsch, O
    Antoch, G
    Kanja, J
    Seeber, S
    Schütte, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 261 - 265
  • [25] Ocular Side Effects Associated with Imatinib Mesylate and Perifosine for Gastrointestinal Stromal Tumor
    Dogan, S. Serdar
    Esmaeli, Bita
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (01) : 109 - +
  • [26] Metachronous Primary Adenocarcinoma of Lung During Adjuvant Imatinib Mesylate Therapy for Gastrointestinal Stromal Tumor of Stomach A Case Report
    Jiang, Meng-jie
    Weng, Shan-Shan
    Cao, Ying
    Li, Xiao-Fen
    Wang, Liu-Hong
    Xu, Jing-Hong
    Yuan, Ying
    MEDICINE, 2015, 94 (36)
  • [27] Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor
    Enck, Robert E.
    Abushahin, Fadi
    Bossaer, John B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (02) : 137 - 140
  • [28] Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
    Sebastian Bauer
    Christopher L. Corless
    Michael C. Heinrich
    Olaf Dirsch
    Gerald Antoch
    Jörg Kanja
    Siegfried Seeber
    Jochen Schütte
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 261 - 265
  • [29] Gastrointestinal stromal tumor: New nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate
    Shankar, S
    vanSonnenberg, E
    Desai, J
    DiPiro, PJ
    Van den Abbeele, A
    Demetri, GD
    RADIOLOGY, 2005, 235 (03) : 892 - 898
  • [30] Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients
    Tatsuo Kanda
    Toshirou Nishida
    Norihito Wada
    Osamu Kobayashi
    Masakazu Yamamoto
    Akira Sawaki
    Narikazu Boku
    Masato Koseki
    Toshihiko Doi
    Yasushi Toh
    Yoshihiro Kakeji
    Toshiro Sugiyama
    Yoshito Komatsu
    Shojiro Kikuchi
    Kyoji Ogoshi
    Hitoshi Katai
    Kazuhito Miyachi
    Seiichi Hirota
    Atsushi Ohtsu
    International Journal of Clinical Oncology, 2013, 18 : 38 - 45
12345